𝔖 Bobbio Scriptorium
✦   LIBER   ✦

High-performance liquid chromatographic assay for 4-nitrophenol hydroxylation, a putative cytochrome P-4502E1 activity, in human liver microsomes

✍ Scribed by Wongwiwat Tassaneeyakul; Maurice E. Veronese; Donald J. Birkett; John O. Miners


Publisher
Elsevier Science
Year
1993
Weight
432 KB
Volume
616
Category
Article
ISSN
0378-4347

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


High-performance liquid chromatographic
✍ Thomas Kronbach; Daniel Mathys; Josef Gut; Therese Catin; Urs A. Meyer 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 669 KB

Bufuralol, debrisoquine, and dextromethorphan are three prototype substrates of the common genetic deficiency of oxidative drug metabolism in man known as debrisoquine/sparteine-type polymorphism. We describe assays for the in vitro metabolism of (+)-and (-)-bufuralol, debrisoquine, and dextromethor

High-performance liquid chromatographic
✍ Nobumitsu Hanioka; Hideto Jinno; Tetsuji Nishimura; Masanori Ando; Shogo Ozawa; 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB 👁 1 views

## Abstract A simple and sensitive assay for glucuronidation activity of 7‐ethyl‐10‐hydroxycamptothecin (SN‐38), the active metabolite of irinotecan (CPT‐11), in human liver microsomes by high‐performance liquid chromatography (HPLC) with fluorescence detection is reported. The method was validated

Validation of higher-throughput high-per
✍ Inhou Chu; Leonard Favreau; Tony Soares; Chin-chung Lin; Amin A. Nomeir 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB 👁 2 views

In the early stage of drug discovery, thousands of new chemical entities (NCEs) may be screened before a single drug candidate can be identified for development. In order to accelerate the drug discovery process, we have developed higher-throughput enzyme assays to evaluate the inhibition of cytochr